Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associations
Open Access
- 7 October 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 147 (12) , 4121-4130
Abstract
Post-mortem studies have shown that patients dying from severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection frequently have pathological changes in their CNS, particularly in the brainstem. Many of these changes are proposed to result from para-infectious and/or post-infection immune responses. Clinical symptoms such as fatigue, breathlessness, and chest pain are frequently reported in post-hospitalized coronavirus disease 2019 (COVID-19) patients. We propose that these symptoms are in part due to damage to key neuromodulatory brainstem nuclei. While brainstem involvement has been demonstrated in the acute phase of the illness, the evidence of long-term brainstem change on MRI is inconclusive. We therefore used ultra-high field (7 T) quantitative susceptibility mapping (QSM) to test the hypothesis that brainstem abnormalities persist in post-COVID patients and that these are associated with persistence of key symptoms. We used 7 T QSM data from 30 patients, scanned 93–548 days after hospital admission for COVID-19 and compared them to 51 age-matched controls without prior history of COVID-19 infection. We correlated the patients’ QSM signals with disease severity (duration of hospital admission and COVID-19 severity scale), inflammatory response during the acute illness (C-reactive protein, D-dimer and platelet levels), functional recovery (modified Rankin scale), depression (Patient Health Questionnaire-9) and anxiety (Generalized Anxiety Disorder-7). In COVID-19 survivors, the MR susceptibility increased in the medulla, pons and midbrain regions of the brainstem. Specifically, there was increased susceptibility in the inferior medullary reticular formation and the raphe pallidus and obscurus. In these regions, patients with higher tissue susceptibility had worse acute disease severity, higher acute inflammatory markers, and significantly worse functional recovery. This study contributes to understanding the long-term effects of COVID-19 and recovery. Using non-invasive ultra-high field 7 T MRI, we show evidence of brainstem pathophysiological changes associated with inflammatory processes in post-hospitalized COVID-19 survivors.Keywords
Funding Information
- NIHR Cambridge Biomedical Research Centre (NIHR203312, BRC-1215-20014)
- NIHR Oxford Biomedical Research Centre (BRC-1215-20008)
- University of Oxford Medical Sciences Division COVID-19 Research Response Fund (0009118)
- Wellcome Trust (103838, 220258)
- Medical Research Council (MC_UU_00030/14)
- Academy of Medical Sciences/The Health Foundation Clinician Scientist Fellowship
- NIHR
- BHF Centre of Research Excellence, Oxford
- Cambridge Centre for Parkinson-Plus
- NIHR Oxford Health Biomedical Research Centre (NIHR203316)
This publication has 60 references indexed in Scilit:
- Chronic Demyelination and Axonal Degeneration in Multiple Sclerosis: Pathogenesis and Therapeutic ImplicationsCurrent Neurology and Neuroscience Reports, 2021
- Long COVID-19—it's not over until?Clinical Microbiology and Infection, 2021
- COVID-19-related intracranial imaging findings: a large single-centre experienceClinical Radiology, 2021
- Neuroanatomical substrates of generalized brain dysfunction in COVID-19Intensive Care Medicine, 2020
- Persistent Symptoms in Patients After Acute COVID-19JAMA, 2020
- C-reactive protein as a biomarker of severe H1N1 influenzaInflammation Research, 2018
- Region‐specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mappingHuman Brain Mapping, 2015
- Mental Morbidities and Chronic Fatigue in Severe Acute Respiratory Syndrome SurvivorsArchives of internal medicine (1960), 2009
- A precious metal: Iron, an essential nutrient for all cellsGenes & Nutrition, 2006
- The NMR phased arrayMagnetic Resonance in Medicine, 1990